SANOFI CORECTION SOHRT POSITION FOR NEW there 's high probability that the price will go to 85.47 as TP 1
SNYNF trade ideas
SANOFI is likely to go bullish .NASDAQ:SNY is showing signs that it is heading up to around the 54.5 area .There is a possibility that It could return back to around the 48 area and then bounce back from there to around the 54.5 area but I think price would rather break significantly above the 50 until around the 54-55 area .
SANOFI SAN* Next target 95 € provided that the price does not break with force 88.6 €
* if the price breaks the red trend line with force next target 98.8 €
* if the price breaks with force 98.8 € the price will fetch 112 € provided that the price does not break the red trend line down
$SNY 4/17 $50 Calls @.20 Looking for next leg in channel to fill gap and more news surrounding the COVID-19 Drug by Sanofi - With Pumper Trump having holdings here. I see this moving to target
www.marketwatch.com
Best Penny Stocks to buy and watch in April 2020 Best Penny Stocks to buy and watch in April 2020 : SNY
😊Please LIKE & FOLLOW for more VIP Hunters signals in Forex , penny stocks and cryptocurrency
Date of the Release : SNY
FDA date of approval - 25th of April
What’s the real story :
The beauty of Penny stock that I trade in particular , They are ALL pharmaceutical companies. The AMAZING part is 90% of Biotech penny stocks get approved , Still there is 10% that will go the other way ! That's why I'm here for my students to scan all the markets and give them the conclusion that I personally apply .
How can you actually use this ?
We ONLY trade regarding the news ! Meaning that when we see the anticipatory run UP I start trading it and letting my students and followers take the advantage 👨🎓.
The Best Part
You can follow me and apply my trades for FREE !!!
QUESTIONS ?
Please comment below , what you have in mind 😊
COVID-19 CURE! manufactured by Sanofi
Sanofi produces Plaquenil, and Quinoric (en.wikipedia.org)
"On 16 March 2020, advisor to the French Government on COVID-19, Professor Didier Raoult, announced that a non-randomized unblinded trial involving 24 people from the south east of France supported the claim that hydroxychloroquine was an effective treatment for COVID-19. The trial is yet to be peer-reviewed. An amount of 600 mg of hydroxychloroquine was administered to these people every day for 10 days. They reported "a significant decrease in viral load". The drug appeared to be responsible for a "rapid and effective speeding up of their healing process, and a sharp decrease in the amount of time they remained contagious"
www.newsweek.com
www.mediterranee-infection.com
On March 17 after testing in several hospitals around Italy the Italian Pharmaceutical Agency has included hydroxychloroquine in the list of drugs with positive preliminary results for treatment of coronavirus disease 2019. See www.aifa.gov.it for details.
On March 19 Trump said:
finance.yahoo.com
I hope this information could help.
Sanofi uptrendSanofi is currently in an uptrend, with a bump and run present, a triple top and a new support formed from the mirror resistance level. A bull flag formation would be indicative of a trendline break.
SNY Bump and RunSNY has experience two bump and runs throughout the course of its listing. Will a third follow? If so will it be immediately or will further trend strengthening occur. The bump and runs also resulted in two triple tops.
FDA approves Dupixent® (dupilumab) for moderate-to-severe atopicREGN,SNY: Sanofi
2019-03-11 15:45:00
FDA approves Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents - PR Newswire
Sanofi: head and shoulders configurationSanofi has developped a head (h) and shoulders (s1 and S2) pattern from 2013 to 2018. During 2018 a strong pullback has been observed to the resistance R. If the pattern is confirmed, price will begin to decrease in the coming weeks.
Objective 1: 68€ (the neckline)
Objective 2:50€
Long SANSanofi after several tries broke its cup & handle formation a successfully retested it. It seems to be also forming a reverse H&S.
Stop: 74.60
Targets: 85.60 / 92.90
SANOFI - Close to low end of long-term uptrendStock price is currently trapped within a small range, but expected to break out soon - either up or down.
Bullish Reversal Built-UpSanofi shares have been plummeting because of lowering net income, disappointing return on equity and performance in the stock itself.
However, market was overreacting and short-term bullish reversal ought to be considered.
SANOFI Is Ready For a ReboundDespite the undeniable bearish momentum, the €63.50 support is a mayor player in Sanofi. It is likely that a rebound towards at least the €68 zone occurs during the next weeks. A second likely bullish target is €71.95.
Good luck fellow traders
